• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CTS Corporation Announces Appointment of Amy M. Dodrill to its Board of Directors

    2/8/24 5:30:00 PM ET
    $CTS
    $PRCT
    Electrical Products
    Technology
    Medical/Dental Instruments
    Health Care
    Get the next $CTS alert in real time by email

    LISLE, Ill., Feb. 08, 2024 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS), a leading global designer and manufacturer of custom engineered solutions that "Sense, Connect and Move," today announced that Amy M. Dodrill has been appointed to its board of directors, effective February 8, 2024, and will serve as a member of the nominating, governance and sustainability and technology and transactions committees.

    Ms. Dodrill comes to CTS with over 25 years of experience in medical and technology companies and a proven track record of successfully leading and profitably growing global businesses serving key end markets. Ms. Dodrill most recently served as President of Baxter's Global Surgical Solutions and Patient Support Systems segment, a $2 billion business with innovative products focused on advancing connected care and patient outcomes. In that role, Ms. Dodrill successfully integrated two former Hillrom business units into Baxter. Ms. Dodrill is a member of the board of directors of Procept BioRobotics (NASDAQ:PRCT), a commercial stage surgical robotics company, serving on the audit and compensation committees.

    "CTS is pleased to welcome Amy Dodrill to the CTS board.   Her extensive experience in the medical end market and background leading global businesses make her a valuable addition to our already highly experienced and diverse group of directors as CTS continues to focus on growth, end-market diversification, and products that sense, connect and move," said Kieran O'Sullivan, Chairman, President and CEO of CTS.

    About CTS

    CTS (NYSE:CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, and transportation markets. For more information, visit www.ctscorp.com.

    Contact

    Ashish Agrawal

    Vice President and Chief Financial Officer

    CTS Corporation

    4925 Indiana Avenue

    Lisle, IL 60532

    USA

    Telephone: +1 (630) 577-8800

    Email: ashish.agrawal@ctscorp.com



    Primary Logo

    Get the next $CTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CTS
    $PRCT

    CompanyDatePrice TargetRatingAnalyst
    PROCEPT BioRobotics Corporation
    $PRCT
    3/6/2026$30.00Neutral
    Robert W. Baird
    PROCEPT BioRobotics Corporation
    $PRCT
    2/26/2026Outperform → Perform
    Oppenheimer
    PROCEPT BioRobotics Corporation
    $PRCT
    2/26/2026$20.00Neutral → Underperform
    BofA Securities
    PROCEPT BioRobotics Corporation
    $PRCT
    12/12/2025$62.00Buy
    UBS
    PROCEPT BioRobotics Corporation
    $PRCT
    12/8/2025$38.00Buy → Neutral
    BofA Securities
    PROCEPT BioRobotics Corporation
    $PRCT
    9/2/2025$60.00Perform → Outperform
    Oppenheimer
    PROCEPT BioRobotics Corporation
    $PRCT
    7/9/2025$70.00Overweight
    Stephens
    PROCEPT BioRobotics Corporation
    $PRCT
    7/7/2025Perform
    Oppenheimer
    More analyst ratings

    $CTS
    $PRCT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Desai Antal Rohit bought $10,482,943 worth of shares (426,262 units at $24.59) (SEC Form 4)

    4 - PROCEPT BioRobotics Corp (0001588978) (Issuer)

    3/9/26 7:19:42 PM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    Director Moll Frederic H bought $785,138 worth of shares (20,000 units at $39.26), increasing direct ownership by 2% to 863,159 units (SEC Form 4)

    4 - PROCEPT BioRobotics Corp (0001588978) (Issuer)

    8/14/25 4:18:26 PM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    $CTS
    $PRCT
    SEC Filings

    View All

    SEC Form SD filed by PROCEPT BioRobotics Corporation

    SD - PROCEPT BioRobotics Corp (0001588978) (Filer)

    6/1/26 5:27:17 PM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    SEC Form SD filed by CTS Corporation

    SD - CTS CORP (0000026058) (Filer)

    5/29/26 10:00:02 AM ET
    $CTS
    Electrical Products
    Technology

    CTS Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - CTS CORP (0000026058) (Filer)

    5/19/26 4:00:14 PM ET
    $CTS
    Electrical Products
    Technology

    $CTS
    $PRCT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO O'Sullivan Kieran M sold $8,484,805 worth of shares (130,000 units at $65.27) as part of a pre-agreed trading plan, decreasing direct ownership by 30% to 307,693 units (SEC Form 4)

    4 - CTS CORP (0000026058) (Issuer)

    6/3/26 5:13:21 PM ET
    $CTS
    Electrical Products
    Technology

    Senior Vice President Hawkins John M was granted 2,010 units of Common Stock (SEC Form 4)

    4 - CTS CORP (0000026058) (Issuer)

    6/3/26 4:00:49 PM ET
    $CTS
    Electrical Products
    Technology

    Chief Operating Officer Trivedi Pratik covered exercise/tax liability with 2,056 shares, decreasing direct ownership by 18% to 9,382 units (SEC Form 4) to satisfy withholding obligation

    4 - CTS CORP (0000026058) (Issuer)

    5/12/26 4:00:19 PM ET
    $CTS
    Electrical Products
    Technology

    $CTS
    $PRCT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $CTS
    $PRCT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval

    SAN JOSE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (NASDAQ:PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: completion of enrollment in the randomized WATER IV study evaluating Aquablation® therapy versus radical prostatectomy, and FDA Investigational Device Exemption (IDE) approval for a second randomized protocol evaluating Aquablation therapy versus active surveillance. The first randomized WATER IV study (WATER IV RP) fully enrolled 280 planned patients and is the only FDA randomized study comparing Aquablation therapy to radical prostatectomy, the established surgical standard of care. Based on current timelines, the Company e

    5/28/26 8:00:00 AM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    CTS Corporation to Present at the 16th Annual East Coast IDEAS Investor Conference

    LISLE, Ill., May 26, 2026 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS) announced today that it will participate in the 16th Annual East Coast IDEAS Investor Conference June 10-11, 2026 at The Westin Times Square in New York, NY. CTS' presentation is scheduled to begin at 9:55 AM EDT on June 11, 2026. You may access a live webcast of the event using this link or from the Investors section of the CTS Corporation website at www.ctscorp.com. The webcast will also be available for replay on the conference website for one year following the presentation. About CTSCTS (NYSE:CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors,

    5/26/26 5:00:00 PM ET
    $CTS
    Electrical Products
    Technology

    CTS Corporation Declares a Dividend

    LISLE, Ill., May 14, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of CTS Corporation (NYSE:CTS) has declared a cash dividend of $0.04 per share on outstanding shares of common stock, without par value, to be paid on July 24, 2026, to shareholders of record at the close of business on June 26, 2026. About CTS CTS Corporation (NYSE:CTS) is a leading designer and manufacturer of products that Sense, Connect and Move. CTS manufactures sensors, actuators and electronic components in North America, Europe and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical and transportation markets. For more information, visit www.ctscorp.com. Contact Ash

    5/14/26 12:13:29 PM ET
    $CTS
    Electrical Products
    Technology

    Robert W. Baird initiated coverage on PROCEPT BioRobotics with a new price target

    Robert W. Baird initiated coverage of PROCEPT BioRobotics with a rating of Neutral and set a new price target of $30.00

    3/6/26 8:35:41 AM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    PROCEPT BioRobotics downgraded by Oppenheimer

    Oppenheimer downgraded PROCEPT BioRobotics from Outperform to Perform

    2/26/26 7:23:22 AM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    PROCEPT BioRobotics downgraded by BofA Securities with a new price target

    BofA Securities downgraded PROCEPT BioRobotics from Neutral to Underperform and set a new price target of $20.00

    2/26/26 7:11:50 AM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    $CTS
    $PRCT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by PROCEPT BioRobotics Corporation

    SC 13G/A - PROCEPT BioRobotics Corp (0001588978) (Subject)

    11/14/24 1:28:32 PM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by CTS Corporation

    SC 13G/A - CTS CORP (0000026058) (Subject)

    11/14/24 1:28:29 PM ET
    $CTS
    Electrical Products
    Technology

    SEC Form SC 13G filed by CTS Corporation

    SC 13G - CTS CORP (0000026058) (Subject)

    11/14/24 12:28:26 PM ET
    $CTS
    Electrical Products
    Technology

    $CTS
    $PRCT
    Leadership Updates

    Live Leadership Updates

    View All

    CTS Corporation Appoints Pratik Trivedi as Chief Operating Officer

    LISLE, Ill. , Nov. 26, 2025 (GLOBE NEWSWIRE) -- CTS Corporation today announced the appointment of Pratik Trivedi to Chief Operating Officer (COO), effective December 5. Mr. Trivedi, who is Senior Vice President at CTS, brings deep industry experience from prior leadership positions at Eaton Corporation and Cummins Inc. "I am very pleased that Pratik will assume the role of COO. His experience, focus and leadership will be important to executing our growth strategy," commented Kieran O'Sullivan, Chairman and CEO of CTS.  "Pratik has demonstrated an ability to lead and deliver results since joining CTS and I am confident that he will be highly effective as COO."   About CTS CTS Corporat

    11/26/25 9:15:00 AM ET
    $CTS
    Electrical Products
    Technology

    CTS Corporation Announces Appointment of Kimberly Banks MacKay to its Board of Directors

    LISLE, Ill., Nov. 06, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS), a leading global designer and manufacturer of custom engineered solutions that "Sense, Connect and Move," today announced that Kimberly Banks MacKay has been appointed to its Board of Directors, effective November 5, 2025, and that she will serve as a member of the Nominating, Governance and Sustainability Committee, as well as the Technology and Transactions Committee. Ms. MacKay comes to CTS with over 30 years of experience driving results in multi-national companies serving key end markets. Ms. MacKay currently serves as SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services, Inc. Ms. MacKa

    11/6/25 9:00:00 AM ET
    $CTS
    Electrical Products
    Technology

    CTS Corporation Announces the Appointment of Mark Pacioni as Chief Legal & Administrative Officer and Corporate Secretary

    LISLE, Ill., July 01, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS) today announced that Mark Pacioni has been appointed Chief Legal & Administrative Officer and Corporate Secretary, effective July 1, 2025. Prior to joining CTS, Mr. Pacioni served as Chief Legal Officer and Secretary of CareerBuilder, LLC from 2019 to 2024 and its successor company, CareerBuilder + Monster, from 2024 until June 2025. Prior thereto, he held senior legal roles at The Boeing Co., Molex, Inc., and Knowles Corp. In addition to his in-house experience, Mr. Pacioni was in private practice representing public companies on transactions and governance matters and was Special Counsel at the U.S. Securities and

    7/1/25 9:00:00 AM ET
    $CTS
    Electrical Products
    Technology

    $CTS
    $PRCT
    Financials

    Live finance-specific insights

    View All

    CTS Corporation Declares a Dividend

    LISLE, Ill., May 14, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of CTS Corporation (NYSE:CTS) has declared a cash dividend of $0.04 per share on outstanding shares of common stock, without par value, to be paid on July 24, 2026, to shareholders of record at the close of business on June 26, 2026. About CTS CTS Corporation (NYSE:CTS) is a leading designer and manufacturer of products that Sense, Connect and Move. CTS manufactures sensors, actuators and electronic components in North America, Europe and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical and transportation markets. For more information, visit www.ctscorp.com. Contact Ash

    5/14/26 12:13:29 PM ET
    $CTS
    Electrical Products
    Technology

    PROCEPT BioRobotics Reports First Quarter 2026 Financial Results

    SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ:PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended March 31, 2026. "Over the past six months, we have taken decisive actions to reset the organization by sharpening our focus on operational excellence, accountability, and commercial discipline, and our first quarter results reflect the early impact of that work," said Larry Wood, Chief Executive Officer. "We delivered $83.1 million in revenue, driven by strong U.S. system sales and improved pricing.

    4/29/26 4:03:00 PM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    CTS Announces First Quarter 2026 Results

    LISLE, Ill., April 29, 2026 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS), a leading global designer and manufacturer of highly engineered solutions that "Sense, Connect and Move," today announced results for the first quarter of 2026. "CTS delivered another quarter of strong performance, with diversified end-market sales up 18% year over year and modest growth in transportation," said Kieran O'Sullivan, CEO of CTS Corporation. "Our teams executed well, driving profitable growth, margin expansion, and strong cash generation. Diversification remains central to our strategy as we continue to strengthen our growth and quality of earnings." First Quarter 2026 Results Sales were $139 millio

    4/29/26 8:00:00 AM ET
    $CTS
    Electrical Products
    Technology